These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 15711039)

  • 1. Endothelin-1 levels and conduit artery mechanical properties in end-stage renal disease.
    Dammers R; Hoeks AP; Tordoir JH; Welten RJ; Hamulyák K; Kooman JP; Kitslaar PJ
    Blood Purif; 2005; 23(3):190-5. PubMed ID: 15711039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kynurenines and oxidative status are independently associated with thrombomodulin and von Willebrand factor levels in patients with end-stage renal disease.
    Pawlak K; Domaniewski T; Mysliwiec M; Pawlak D
    Thromb Res; 2009 Sep; 124(4):452-7. PubMed ID: 19477487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local shear stress and brachial artery functions in end-stage renal disease.
    Verbeke FH; Agharazii M; Boutouyrie P; Pannier B; Guérin AP; London GM
    J Am Soc Nephrol; 2007 Feb; 18(2):621-8. PubMed ID: 17202423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors.
    Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Horký K; Aschermann M
    J Hum Hypertens; 2002 Aug; 16(8):557-62. PubMed ID: 12149661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raynaud's phenomenon and endothelial dysfunction in end-stage renal disease patients treated with hemodialysis.
    Czupryniak A; Kałuzyńska A; Nowicki M; Wiecek B; Bald E; Owczarek D
    Kidney Blood Press Res; 2005; 28(1):27-31. PubMed ID: 15452382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carotid artery stiffness in patients with end-stage renal disease: no effect of long-term homocysteine-lowering therapy.
    van Guldener C; Lambert J; ter Wee PM; Donker AJ; Stehouwer CD
    Clin Nephrol; 2000 Jan; 53(1):33-41. PubMed ID: 10661480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of exercise stress testing on soluble E-selectin, von Willebrand factor, and circulating endothelial cells as indices of endothelial damage/dysfunction.
    Boos CJ; Balakrishnan B; Lip GY
    Ann Med; 2008; 40(1):66-73. PubMed ID: 17934907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. von Willebrand factor binding to collagen in patients with end-stage renal disease.
    Niesvizky R; Calandri C; Patel ND; Zhou SL; Potter BJ; Rand JH
    J Lab Clin Med; 1994 Jan; 123(1):137-42. PubMed ID: 8288954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive markers of asymptomatic atherosclerosis in end-stage renal disease patients.
    Mutluay R; Konca C; Erten Y; Paşaoğlu H; Değer SM; Ağirgün C; Derici U; Arinsoy T; Sindel S
    Ren Fail; 2010 May; 32(4):448-54. PubMed ID: 20446782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure.
    Kos T; Pacher R; Wimmer A; Bojic A; Hülsmann M; Frey B; Mayer G; Yilmaz N; Skvarilova L; Spinar J; Vitovec J; Toman J; Woloszcuk W; Stanek B
    Wien Klin Wochenschr; 1998 Feb; 110(3):89-95. PubMed ID: 9553203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin and cardiovascular remodeling in end-stage renal disease and co-morbid diabetes mellitus.
    Karakitsos D; De Groot E; Patrianakos AP; Parthenakis F; Boletis J; Karabinis A; Kyriazis J; Vardas P; Daphnis E
    Am J Nephrol; 2006; 26(4):340-7. PubMed ID: 16825760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial dysfunction and oxidative stress in type 1 and type 2 diabetic patients without clinical macrovascular complications.
    De Mattia G; Bravi MC; Laurenti O; Moretti A; Cipriani R; Gatti A; Mandosi E; Morano S
    Diabetes Res Clin Pract; 2008 Feb; 79(2):337-42. PubMed ID: 17949845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A preliminary study on the markers of pulmonary vascular endothelial cells in patients with ARDS].
    Li Q; Qian G; Chen Z
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Sep; 22(9):533-5. PubMed ID: 11776764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes.
    Lee KW; Blann AD; Lip GY
    Int J Cardiol; 2006 Aug; 111(2):302-8. PubMed ID: 16324758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular resistance and endothelial function in cyclosporine-treated lung transplant recipients.
    Silverborn M; Ambring A; Nilsson F; Friberg P; Jeppsson A
    Transpl Int; 2006 Dec; 19(12):974-81. PubMed ID: 17081226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endothelin, endothelial cells and von Willebrand factor in peripheral blood of asthmatic patients].
    Krasnowska M; Nittner-Marszalska M; Krasnowski R; Kopeć W
    Pol Merkur Lekarski; 2002 Jun; 12(72):445-8. PubMed ID: 12362657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epoxyeicosatrienoic acids contribute with altered nitric oxide and endothelin-1 pathways to conduit artery endothelial dysfunction in essential hypertension.
    Bellien J; Iacob M; Remy-Jouet I; Lucas D; Monteil C; Gutierrez L; Vendeville C; Dreano Y; Mercier A; Thuillez C; Joannides R
    Circulation; 2012 Mar; 125(10):1266-75. PubMed ID: 22412088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient characteristics rather than the type of dialyser predict the variability of endothelial derived surface molecules in chronic haemodialysis patients.
    Grooteman MP; Gritters M; Wauters IM; Schalkwijk CG; Stam F; Twisk J; Ter Wee PM; Nubé MJ
    Nephrol Dial Transplant; 2005 Dec; 20(12):2751-8. PubMed ID: 16188898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplified biochemical activation of endothelial function in hypertension associated with moderate to severe renal failure.
    Cottone S; Mulè G; Amato F; Riccobene R; Vadalà A; Lorito MC; Raspanti F; Cerasola G
    J Nephrol; 2002; 15(6):643-8. PubMed ID: 12495277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired resistance artery function in patients with end-stage renal disease.
    Luksha N; Luksha L; Carrero JJ; Hammarqvist F; Stenvinkel P; Kublickiene K
    Clin Sci (Lond); 2011 Jun; 120(12):525-36. PubMed ID: 21222655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.